Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era.

COVID-19 dialysis immunosuppression kidney transplantation outcomes transplant waitlist

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 07 09 2020
revised: 15 10 2020
accepted: 27 10 2020
pubmed: 12 11 2020
medline: 12 11 2020
entrez: 11 11 2020
Statut: ppublish

Résumé

There are limited data pertaining to comparative outcomes of remaining on dialysis versus kidney transplantation as the threat of coronavirus disease 2019 (COVID-19) remains. In this study we delineate the differential risks involved using serologic methods to help define exposure rates. From a cohort of 1433 patients with end-stage kidney disease (ESKD), we analyzed COVID-19 infection rates and outcomes in 299 waitlist patients compared with 237 transplant recipients within their first year post-transplant. Patients were followed over a 68-day period from the time our transplant program closed due to COVID-19. The overall mortality rates in waitlist and transplant populations were equivalent ( Although COVID-19 infection was more common in the waitlist patients, a higher COVID-19‒associated mortality rate was seen in the transplant recipients, resulting in comparable overall mortality rates.

Identifiants

pubmed: 33173838
doi: 10.1016/j.ekir.2020.10.032
pii: S2468-0249(20)31703-4
pmc: PMC7644242
doi:

Types de publication

Journal Article

Langues

eng

Pagination

46-55

Investigateurs

Maura Appelbe (M)
Edwina Brown (E)
Tom Cairns (T)
Caroline Clerkin (C)
Marie Condon (M)
Richard W Corbett (RW)
Jeremy Crane (J)
Frank Dor (F)
Neill Duncan (N)
Claire Edwards (C)
Fabiana Fernandes da Costa (F)
Andrew Frankel (A)
Dawn Goodall (D)
Julie Harris (J)
Sharon Harris (S)
Paul Herbert (P)
Peter Hill (P)
Andreas Kousios (A)
Jeremy B Levy (JB)
Lian Liu (L)
Marina Loucaidou (M)
Kathleen Lynch (K)
Nicholas Medjeral-Thomas (N)
Dihlabelo Moabi (D)
Anand Muthusamy (A)
Margaret Nevin (M)
Andrew Palmer (A)
Darren Parsons (D)
Virginia Prout (V)
Sue Punzalan (S)
Emma Salisbury (E)
Eleanor Sandhu (E)
Colin Smith (C)
Roland Storey (R)
Anisha Tanna (A)
Katie Tansey (K)
David Thomas (D)
James Tomlinson (J)
Vassilios Papalois (V)
Phil Webster (P)
Dejing Yang (D)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.

Références

Pharmacotherapy. 2020 Jun;40(6):517-524
pubmed: 32339304
Transplantation. 2014 Feb 27;97(4):433-9
pubmed: 24430742
Lancet. 2020 May 23;395(10237):e95-e96
pubmed: 32407668
Kidney Int. 2005 Nov;68(5):2345-51
pubmed: 16221239
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Ann Neurol. 2020 Jun;87(6):794-797
pubmed: 32383812
Ann Rheum Dis. 2020 May;79(5):667-668
pubmed: 32241793
J Am Soc Nephrol. 2020 Jun;31(6):1145-1146
pubmed: 32312797
Am J Transplant. 2020 Jul;20(7):1800-1808
pubmed: 32330343
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
J Am Soc Nephrol. 2020 Aug;31(8):1815-1823
pubmed: 32561681
Am J Transplant. 2020 Jul;20(7):1826-1836
pubmed: 32323460
Kidney Int. 2009 Feb;75(3):317-26
pubmed: 19020531
Am J Transplant. 2020 Jul;20(7):1849-1858
pubmed: 32301155
Nat Rev Nephrol. 2020 Jun;16(6):311-313
pubmed: 32249840
J Am Soc Nephrol. 2020 Jun;31(6):1150-1156
pubmed: 32317402
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397
pubmed: 32385130
N Engl J Med. 1999 Dec 2;341(23):1725-30
pubmed: 10580071

Auteurs

Candice Clarke (C)

Centre for Inflammatory Disease, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.

Gaetano Lucisano (G)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Maria Prendecki (M)

Centre for Inflammatory Disease, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.

Sarah Gleeson (S)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Paul Martin (P)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Mahrukh Ali (M)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Stephen P McAdoo (SP)

Centre for Inflammatory Disease, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.
Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Liz Lightstone (L)

Centre for Inflammatory Disease, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.
Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Damien Ashby (D)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Rawya Charif (R)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Megan Griffith (M)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Adam McLean (A)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Frank Dor (F)

Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Michelle Willicombe (M)

Centre for Inflammatory Disease, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.
Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.

Classifications MeSH